The Arg/N-Degron Pathway—A Potential Running Back in Fine-Tuning the Inflammatory Response?

Total Page:16

File Type:pdf, Size:1020Kb

The Arg/N-Degron Pathway—A Potential Running Back in Fine-Tuning the Inflammatory Response? biomolecules Article The Arg/N-Degron Pathway—A Potential Running Back in Fine-Tuning the Inflammatory Response? Dominique Leboeuf 1 , Maxim Pyatkov 2 , Timofei S. Zatsepin 1 and Konstantin Piatkov 1,* 1 Skolkovo Institute of Science and Technology, 121205 Moscow, Russia; [email protected] (D.L.); [email protected] (T.S.Z.) 2 Institute of Mathematical Problems of Biology, Keldysh Institute of Applied Mathematics, Russian Academy of Sciences, Pushchino, 142290 Moscow, Russia; [email protected] * Correspondence: [email protected] Received: 12 May 2020; Accepted: 12 June 2020; Published: 14 June 2020 Abstract: Recognition of danger signals by a cell initiates a powerful cascade of events generally leading to inflammation. Inflammatory caspases and several other proteases become activated and subsequently cleave their target proinflammatory mediators. The irreversible nature of this process implies that the newly generated proinflammatory fragments need to be sequestered, inhibited, or degraded in order to cancel the proinflammatory program or prevent chronic inflammation. The Arg/N-degron pathway is a ubiquitin-dependent proteolytic pathway that specifically degrades protein fragments bearing N-degrons, or destabilizing residues, which are recognized by the E3 ligases of the pathway. Here, we report that the Arg/N-degron pathway selectively degrades a number of proinflammatory fragments, including some activated inflammatory caspases, contributing in tuning inflammatory processes. Partial ablation of the Arg/N-degron pathway greatly increases IL-1β secretion, indicating the importance of this ubiquitous pathway in the initiation and resolution of inflammation. Thus, we propose a model wherein the Arg/N-degron pathway participates in the control of inflammation in two ways: in the generation of inflammatory signals by the degradation of inhibitory anti-inflammatory domains and as an “off switch” for inflammatory responses through the selective degradation of proinflammatory fragments. Keywords: Arg/N-degron pathway; UBR-ubiquitin ligases; ubiquitin; proteolysis; inflammatory caspases; inflammation 1. Introduction Recognition of a danger signal triggers a coordinated cascade of events, initiating the inflammatory response. In cells of the innate immune system such as neutrophils, granulocytes, or macrophages, danger signals lead to activation of inflammatory caspases (caspases-1, -4, -5, -11, and -12) [1,2] and subsequent proteolysis of a multitude of proinflammatory targets, including IL-1β and various activators of inflammation [3,4]. In the adaptive immune system, cytotoxic T lymphocytes (CTL) and natural killer (NK) cells influence proinflammatory cytokine secretion through the action of granzymes [5,6]. In a more general manner, inflammation can also be initiated through activation of the NF-κB pathway; triggering the transcription of numerous proinflammatory genes; and inducing the production of cytokines, chemokines, and additional proinflammatory mediators [7]. Proinflammatory fragments generated by inflammatory caspases are irreversibly modified, and only sequestration or degradation of the fragments will lead to the resolution of the inflammatory response. Ubiquitylation is known to regulate many inflammatory pathways such as those mediated by Toll-like receptors, NOD-like receptors, and cytokine receptors, all of which can initiate the NF-κB pathway, which is itself being tightly controlled by adding or removing ubiquitin chains [8,9]. Biomolecules 2020, 10, 903; doi:10.3390/biom10060903 www.mdpi.com/journal/biomolecules Biomolecules 2020, 10, 903 2 of 16 For instance, the processing of NF-κB precursors, activation of the IκB kinase (IKK) complex, andBiomolecules degradation 2020, 10 of, x the NF-κB inhibitor IκB all require ubiquitylation [10,11]. More specifically,2 of 15 when cleaved by calpains during sepsis or other inflammatory settings [12], the NF-κB inhibitor IκBα can bedegradation degraded of by the the NF- Argκ/BN-degron inhibitor I pathway,κB all require due toubiquitylation the presence [10,11]. of the More destabilizing specifically, residue when Glu at the newlycleaved exposed by calpains N-terminus during sepsis [13]. or The other negative inflammatory regulation settings of [12], inflammation the NF-κB inhibitor is generally IκBα provided can by deubiquitinatingbe degraded by the enzymes, Arg/N-degron which pathway, remove due the ubiquitin-activatingto the presence of the destabilizing signal [8,14 ].residue However, Glu at recent the newly exposed N-terminus [13]. The negative regulation of inflammation is generally provided evidence suggests that the resolution of inflammation could also be mediated by E3 ligases and protein by deubiquitinating enzymes, which remove the ubiquitin-activating signal [8,14]. However, recent degradationevidence throughsuggests Lys48-linkedthat the resolution ubiquitin of inflamma chainstion [15 could–17]. also An examplebe mediated is the by controlE3 ligases of and cytokine signalingprotein provided degradation by thethrough E3 ligases Lys48-linked Suppressor ubiquitin of Cytokinechains [15–17]. (SOC) An signaling example is proteins, the control which of are themselvescytokine regulated signaling byprovided ubiquitin-mediated by the E3 ligases degradation Suppressor [18 of]. Cytokine (SOC) signaling proteins, whichThe N-degron are themselves pathway regulated is a proteolyticby ubiquitin-mediated pathway thatdegradation relates the[18].in vivo half-life of a protein to the identityThe of N-degron its N-terminal pathway residue is a proteolytic [19]. N-degrons pathway that comprise relates athe destabilizing in vivo half-life residue, of a protein which to can be recognizedthe identity by an of E3its N-terminal ubiquitin ligase,residue as[19]. well N-degr as anons internal comprise lysine a destabilizing that acts asresidue, the polyubiquitylation which can be site.recognized N-degrons, by generally an E3 ubiquitin formed ligase, after as the well cleavage as an internal of proteins lysine by that exo- acts or as endopeptidases the polyubiquitylation[13,20 –22], site. N-degrons, generally formed after the cleavage of proteins by exo- or endopeptidases [13,20–22], are recognized by specific E3 ubiquitin ligases (N-recognins) that target the proteins for degradation are recognized by specific E3 ubiquitin ligases (N-recognins) that target the proteins for degradation through the proteasome or autophagy [23,24]. In mammals, these E3 ligases are UBR1, UBR2, UBR4, through the proteasome or autophagy [23,24]. In mammals, these E3 ligases are UBR1, UBR2, UBR4, andand UBR5 UBR5 [25 [25].]. The The eukaryote N-degron N-degron pathway pathway consis consiststs of five branches of five branches [19], including [19], the including Arg/N- the Arg/N-degrondegron pathway, pathway, which which targets targets specific specific nonacetyla nonacetylatedted N-terminal N-terminal residues residues(Figure 1) (Figure [26]. The1)[ 26]. Theprimary destabilizing destabilizing N-terminal N-terminal residues residues are direct arely recognized directly recognized by E3 ligases, by whereas E3 ligases, N-terminal whereas N-terminalAsp, Glu, Asp, Asn, Glu,Gln, and Asn, Cys Gln, amino and acids Cys function amino as acids destabilizing function residues as destabilizing through their residues preliminary through theirmodifications, preliminary modifications,such as N-terminal such arginylation as N-terminal by the arginylation ATE1 arginyl-transferase by the ATE1 arginyl-transferase(R-transferase) (R-transferase)(Figure 1) [26,27]. (Figure 1)[26,27]. Figure 1. The mammalian Arg/N-degron pathway. N-terminal residues are indicated by single-letter abbreviationsFigure 1. The for mammalian amino acids, Arg/N-degron and the rest pathway. of a protein N-termin substrateal residues is representedare indicated by single-letter orange spheres. “Primary”,abbreviations “secondary”, for amino andacids, “tertiary” and the rest denote of a pr mechanisticallyotein substrate is represented distinct subsets by orange of destabilizingspheres. N-terminal“Primary”, residues. “secondary”, C* denotesand “tertiary” oxidized denote N-terminal mechanistically Cys, distinct either su Cys-sulfinatebsets of destabilizing or -sulfonate. N- The mammalianterminal residues. N-recognins C* denotes UBR1, oxidized UBR2, N-terminal UBR4, and Cys, UBR5 either (EDD) Cys-sulfin have multipleate or -sulfonate. substrate-binding The sitesmammalian that recognize N-recognins internal UBR1, and terminalUBR2, UBR4, N-degrons and UBR5 and (EDD) target have them multiple to thesubstrate-binding proteasome. sites MetAPs: methioninethat recognize aminopeptidase, internal and NTAN1: terminal N-terminal N-degron asparagines and target amidohydrolase, them to the proteasome. and NTAQ1: MetAPs: N-terminal glutaminemethionine amidohydrolase aminopeptidase, (adapted NTAN1: from N-terminal [21]). asparagine amidohydrolase, and NTAQ1: N- terminal glutamine amidohydrolase (adapted from [21]). Through the selective degradation of proteins, the mammalian Arg/N-degron pathway mediates multipleThrough biological the functions, selective degradation including theof proteins regulation, the mammalian of apoptosis, Arg/N-degron repression pathway of neurodegeneration, mediates multiple biological functions, including the regulation of apoptosis, repression of neurodegeneration, the elimination of aberrant proteins during stress, as well as the regulation of vascular development Biomolecules 2020, 10, 903 3 of 16 and cell motility ([19] and references therein). The regulation
Recommended publications
  • A Family of Mammalian E3 Ubiquitin Ligases That Contain the UBR Box Motif and Recognize N-Degrons Takafumi Tasaki,1 Lubbertus C
    MOLECULAR AND CELLULAR BIOLOGY, Aug. 2005, p. 7120–7136 Vol. 25, No. 16 0270-7306/05/$08.00ϩ0 doi:10.1128/MCB.25.16.7120–7136.2005 Copyright © 2005, American Society for Microbiology. All Rights Reserved. A Family of Mammalian E3 Ubiquitin Ligases That Contain the UBR Box Motif and Recognize N-Degrons Takafumi Tasaki,1 Lubbertus C. F. Mulder,2 Akihiro Iwamatsu,3 Min Jae Lee,1 Ilia V. Davydov,4† Alexander Varshavsky,4 Mark Muesing,2 and Yong Tae Kwon1* Center for Pharmacogenetics and Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania 152611; Aaron Diamond AIDS Research Center, The Rockefeller University, New York, New York 100162; Protein Research Network, Inc., Yokohama, Kanagawa 236-0004, Japan3; and Division of Biology, California Institute of Technology, Pasadena, California 911254 Received 15 March 2005/Returned for modification 27 April 2005/Accepted 13 May 2005 A subset of proteins targeted by the N-end rule pathway bear degradation signals called N-degrons, whose determinants include destabilizing N-terminal residues. Our previous work identified mouse UBR1 and UBR2 as E3 ubiquitin ligases that recognize N-degrons. Such E3s are called N-recognins. We report here that while double-mutant UBR1؊/؊ UBR2؊/؊ mice die as early embryos, the rescued UBR1؊/؊ UBR2؊/؊ fibroblasts still retain the N-end rule pathway, albeit of lower activity than that of wild-type fibroblasts. An affinity assay for proteins that bind to destabilizing N-terminal residues has identified, in addition to UBR1 and UBR2, a huge (570 kDa) mouse protein, termed UBR4, and also the 300-kDa UBR5, a previously characterized mammalian E3 known as EDD/hHYD.
    [Show full text]
  • A Yeast Phenomic Model for the Influence of Warburg Metabolism on Genetic Buffering of Doxorubicin Sean M
    Santos and Hartman Cancer & Metabolism (2019) 7:9 https://doi.org/10.1186/s40170-019-0201-3 RESEARCH Open Access A yeast phenomic model for the influence of Warburg metabolism on genetic buffering of doxorubicin Sean M. Santos and John L. Hartman IV* Abstract Background: The influence of the Warburg phenomenon on chemotherapy response is unknown. Saccharomyces cerevisiae mimics the Warburg effect, repressing respiration in the presence of adequate glucose. Yeast phenomic experiments were conducted to assess potential influences of Warburg metabolism on gene-drug interaction underlying the cellular response to doxorubicin. Homologous genes from yeast phenomic and cancer pharmacogenomics data were analyzed to infer evolutionary conservation of gene-drug interaction and predict therapeutic relevance. Methods: Cell proliferation phenotypes (CPPs) of the yeast gene knockout/knockdown library were measured by quantitative high-throughput cell array phenotyping (Q-HTCP), treating with escalating doxorubicin concentrations under conditions of respiratory or glycolytic metabolism. Doxorubicin-gene interaction was quantified by departure of CPPs observed for the doxorubicin-treated mutant strain from that expected based on an interaction model. Recursive expectation-maximization clustering (REMc) and Gene Ontology (GO)-based analyses of interactions identified functional biological modules that differentially buffer or promote doxorubicin cytotoxicity with respect to Warburg metabolism. Yeast phenomic and cancer pharmacogenomics data were integrated to predict differential gene expression causally influencing doxorubicin anti-tumor efficacy. Results: Yeast compromised for genes functioning in chromatin organization, and several other cellular processes are more resistant to doxorubicin under glycolytic conditions. Thus, the Warburg transition appears to alleviate requirements for cellular functions that buffer doxorubicin cytotoxicity in a respiratory context.
    [Show full text]
  • The Ubr2 Gene Is Expressed in Skeletal Muscle Atrophying As a Result of Hind Limb Suspension, but Not Merg1a Expression Alone.." Eur J Transl Myol 24, No
    Southern Illinois University Carbondale OpenSIUC Publications Department of Anatomy 3-31-2014 The br2U gene is expressed in skeletal muscle atrophying as a result of hind limb suspension, but not Merg1a expression alone. Gregory H Hockerman Nicole M Dethrow Sohaib Hameed Maureen Doran Christine Jaeger See next page for additional authors Follow this and additional works at: http://opensiuc.lib.siu.edu/anat_pubs Creative Commons Attribution Non-Commercial License 3.0 Recommended Citation Hockerman, Gregory H, Dethrow, Nicole M, Hameed, Sohaib, Doran, Maureen, Jaeger, Christine, Wang, Wen-Horng and Pond, Amber L. "The Ubr2 gene is expressed in skeletal muscle atrophying as a result of hind limb suspension, but not Merg1a expression alone.." Eur J Transl Myol 24, No. 3 (Mar 2014): 173-179. This Article is brought to you for free and open access by the Department of Anatomy at OpenSIUC. It has been accepted for inclusion in Publications by an authorized administrator of OpenSIUC. For more information, please contact [email protected]. Authors Gregory H Hockerman, Nicole M Dethrow, Sohaib Hameed, Maureen Doran, Christine Jaeger, Wen-Horng Wang, and Amber L Pond This article is available at OpenSIUC: http://opensiuc.lib.siu.edu/anat_pubs/9 Hind Limb Suspension, but not Merg1a, Yields Ubr2 Expression Eur J Trans Myol - Basic Appl Myol 2014; 24 (3): 173-179 The Ubr2 gene is expressed in skeletal muscle atrophying as a result of hind limb suspension, but not Merg1a expression alone Gregory H. Hockerman (1), Nicole M. Dethrow (2), Sohaib Hameed (2), Maureen Doran (2), Christine Jaeger (3), Wen-Horng Wang (1), Amber L.
    [Show full text]
  • The E3 Ligase UBR2 Regulates Cell Death Under Caspase Deficiency Via Erk/MAPK Pathway
    Villa et al. Cell Death and Disease (2020) 11:1041 https://doi.org/10.1038/s41419-020-03258-3 Cell Death & Disease ARTICLE Open Access The E3 ligase UBR2 regulates cell death under caspase deficiency via Erk/MAPK pathway Elodie Villa1,RachelPaul1, Ophélie Meynet1, Sophie Volturo2, Guillaume Pinna 2 and Jean-Ehrland Ricci 1 Abstract Escape from cell death is a key event in cancer establishment/progression. While apoptosis is often considered as the main cell death pathway, upon caspase inhibition, cell death is rather delayed than blocked leading to caspase- independent cell death (CICD). Although described for years, CICD’s underlying mechanism remains to be identified. Here, we performed a genome-wide siRNA lethality screening and identified the RING-Type E3 Ubiquitin Transferase (UBR2) as a specific regulator of CICD. Strikingly, UBR2 downregulation sensitized cells towards CICD while its overexpression was protective. We established that UBR2-dependent protection from CICD was mediated by the MAPK/Erk pathway. We then observed that UBR2 is overexpressed in several cancers, especially in breast cancers and contributes to CICD resistance. Therefore, our work defines UBR2 as a novel regulator of CICD, found overexpressed in cancer cells, suggesting that its targeting may represent an innovative way to kill tumor cells. Introduction the mitochondria interacts with Apaf-1. This interaction The process of cell death affects essentially all cell types will result in the oligomerisation of Apaf-1 and recruit- 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; in multicellular animals. Programmed cell death (PCD) ment of caspase-9 forming therefore a large structure regroups a wide range of molecular mechanisms showing called the apoptosome.
    [Show full text]
  • Stability and Activity of Naturally Occurring RGS2 Variants
    Western University Scholarship@Western Electronic Thesis and Dissertation Repository 8-10-2015 12:00 AM Stability and Activity of Naturally Occurring RGS2 Variants Patrick Stockwell The Unviersity of Western Ontario Supervisor Peter Chidiac The University of Western Ontario Graduate Program in Physiology and Pharmacology A thesis submitted in partial fulfillment of the equirr ements for the degree in Master of Science © Patrick Stockwell 2015 Follow this and additional works at: https://ir.lib.uwo.ca/etd Part of the Cellular and Molecular Physiology Commons Recommended Citation Stockwell, Patrick, "Stability and Activity of Naturally Occurring RGS2 Variants" (2015). Electronic Thesis and Dissertation Repository. 3004. https://ir.lib.uwo.ca/etd/3004 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. STABILITY AND ACTIVITY OF NATURALLY OCCURRING RGS2 VARIANTS Thesis Format: Monograph by Patrick, Stockwell Graduate Program in Physiology and Pharmacology A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science The School of Graduate and Postdoctoral Studies The University of Western Ontario London, Ontario, Canada © Patrick Stockwell 2015 ABSTRACT Regulator of G protein signaling protein 2 (RGS2) attenuates G Protein-Coupled Receptor (GPCR) signaling by promoting the hydrolysis of GTP in the activated Gα subunit to GDP, thereby governing many physiological and pathophysiological signals. However, how RGS2 itself is regulated remains to be elucidated. In this study, our principal goal was to discover the molecular mechanisms controlling RGS2 degradation and if altered degradation affects Gα signaling.
    [Show full text]
  • Title: a Yeast Phenomic Model for the Influence of Warburg Metabolism on Genetic
    bioRxiv preprint doi: https://doi.org/10.1101/517490; this version posted January 15, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 Title Page: 2 3 Title: A yeast phenomic model for the influence of Warburg metabolism on genetic 4 buffering of doxorubicin 5 6 Authors: Sean M. Santos1 and John L. Hartman IV1 7 1. University of Alabama at Birmingham, Department of Genetics, Birmingham, AL 8 Email: [email protected], [email protected] 9 Corresponding author: [email protected] 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 1 bioRxiv preprint doi: https://doi.org/10.1101/517490; this version posted January 15, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 26 Abstract: 27 Background: 28 Saccharomyces cerevisiae represses respiration in the presence of adequate glucose, 29 mimicking the Warburg effect, termed aerobic glycolysis. We conducted yeast phenomic 30 experiments to characterize differential doxorubicin-gene interaction, in the context of 31 respiration vs. glycolysis. The resulting systems level biology about doxorubicin 32 cytotoxicity, including the influence of the Warburg effect, was integrated with cancer 33 pharmacogenomics data to identify potentially causal correlations between differential 34 gene expression and anti-cancer efficacy.
    [Show full text]
  • Impaired Neurogenesis and Cardiovascular Development in Mice Lacking the E3 Ubiquitin Ligases UBR1 and UBR2 of the N-End Rule Pathway
    Impaired neurogenesis and cardiovascular development in mice lacking the E3 ubiquitin ligases UBR1 and UBR2 of the N-end rule pathway Jee Young An*, Jai Wha Seo*, Takafumi Tasaki*, Min Jae Lee*, Alexander Varshavsky†‡, and Yong Tae Kwon*‡ *Center for Pharmacogenetics and Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261; and †Division of Biology, California Institute of Technology, Pasadena, CA 91125 Contributed by Alexander Varshavsky, March 2, 2006 The N-end rule relates the in vivo half-life of a protein to the residues (12–15). The latter are recognized by E3 Ub ligases of the identity of its N-terminal residue. A subset of degradation signals N-end rule pathway (Fig. 1A). In mammals and other eukaryotes recognized by the N-end rule pathway comprises the signals, called that produce nitric oxide (NO), the set of arginylated residues N-degrons, whose determinants include destabilizing N-terminal contains not only Asp and Glu but also N-terminal Cys, which is residues. Our previous work identified a family of at least four arginylated after its oxidation. The latter requires both NO and mammalian E3 ubiquitin ligases, including UBR1 and UBR2, that oxygen (O2) (Fig. 1A) (14, 15). The functions of the N-end rule share the UBR box and recognize N-degrons. These E3 enzymes pathway include the control of peptide import (through the con- mediate the multifunctional N-end rule pathway, but their indi- ditional degradation of import’s repressor) (16, 17), the fidelity of vidual roles are just beginning to emerge. Mutations of UBR1 in chromosome segregation (through the degradation of a condition- humans are the cause of Johanson–Blizzard syndrome.
    [Show full text]
  • T-, B-And NK-Lymphoid, but Not Myeloid Cells Arise from Human
    Leukemia (2007) 21, 311–319 & 2007 Nature Publishing Group All rights reserved 0887-6924/07 $30.00 www.nature.com/leu ORIGINAL ARTICLE T-, B- and NK-lymphoid, but not myeloid cells arise from human CD34 þ CD38ÀCD7 þ common lymphoid progenitors expressing lymphoid-specific genes I Hoebeke1,3, M De Smedt1, F Stolz1,4, K Pike-Overzet2, FJT Staal2, J Plum1 and G Leclercq1 1Department of Clinical Chemistry, Microbiology and Immunology, Ghent University Hospital, Ghent, Belgium and 2Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands Hematopoietic stem cells in the bone marrow (BM) give rise to share a direct common progenitor either, as CLPs were not all blood cells. According to the classic model of hematopoi- found in the fetal liver.5 Instead, fetal B and T cells would esis, the differentiation paths leading to the myeloid and develop through B/myeloid and T/myeloid intermediates. lymphoid lineages segregate early. A candidate ‘common 6 lymphoid progenitor’ (CLP) has been isolated from The first report of a human CLP came from Galy et al. who À þ CD34 þ CD38À human cord blood cells based on CD7 expres- showed that a subpopulation of adult and fetal BM Lin CD34 sion. Here, we confirm the B- and NK-differentiation potential of cells expressing the early B- and T-cell marker CD10 is not þ À þ CD34 CD38 CD7 cells and show in addition that this capable of generating monocytic, granulocytic, erythroid or population has strong capacity to differentiate into T cells. As megakaryocytic cells, but can differentiate into dendritic cells, CD34 þ CD38ÀCD7 þ cells are virtually devoid of myeloid B, T and NK cells.
    [Show full text]
  • Signaling Pathways Regulated by UBR Box-Containing E3 Ligases
    International Journal of Molecular Sciences Review Signaling Pathways Regulated by UBR Box-Containing E3 Ligases Jung Gi Kim 1,2,†, Ho-Chul Shin 3,† , Taewook Seo 1,2, Laxman Nawale 1,2, Goeun Han 1,2, Bo Yeon Kim 1,2,*, Seung Jun Kim 2,3,* and Hyunjoo Cha-Molstad 1,2,* 1 Anticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 28116, Korea; [email protected] (J.G.K.); [email protected] (T.S.); [email protected] (L.N.); [email protected] (G.H.) 2 Department of Biomolecular Science, KRIBB School, University of Science and Technology, Daejeon 34113, Korea 3 Disease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Korea; [email protected] * Correspondence: [email protected] (B.Y.K.); [email protected] (S.J.K.); [email protected] (H.C.-M.); Tel.: +82-43-240-6257 (B.Y.K. & S.J.K. & H.C.-M.) † These authors equally contributed to this work. Abstract: UBR box E3 ligases, also called N-recognins, are integral components of the N-degron path- way. Representative N-recognins include UBR1, UBR2, UBR4, and UBR5, and they bind destabilizing N-terminal residues, termed N-degrons. Understanding the molecular bases of their substrate recog- nition and the biological impact of the clearance of their substrates on cellular signaling pathways can provide valuable insights into the regulation of these pathways. This review provides an overview of the current knowledge of the binding mechanism of UBR box N-recognin/N-degron interactions and their roles in signaling pathways linked to G-protein-coupled receptors, apoptosis, mitochondrial Citation: Kim, J.G.; Shin, H.-C.; Seo, quality control, inflammation, and DNA damage.
    [Show full text]
  • Review on Genomic Regions and Candidate Genes Associated with Economically Important Production and Reproduction Traits in Sheep (Ovies Aries)
    animals Review Review on Genomic Regions and Candidate Genes Associated with Economically Important Production and Reproduction Traits in Sheep (Ovies aries) Gebremedhin Gebreselassie 1,2,3 , Haile Berihulay 1,2, Lin Jiang 1,2 and Yuehui Ma 1,2,* 1 Key Laboratory of Animal (Poultry) Genetics Breeding and Reproduction, Ministry of Agriculture, Institute of Animal Science, Chinese Academy of Agricultural Sciences (CAAS), Beijing 100193, China; [email protected] (G.G.); [email protected] (H.B.); [email protected] (L.J.) 2 National Germplasm Center of Domestic Animal Resources, Institute of Animal Science, Chinese Academy of Agricultural Sciences (CAAS), Beijing 100193, China 3 Department of Agricultural Biotechnology, Biotechnology Center, Ethiopian Biotechnology Institute, Ministry of Innovation and Technology, Addis Ababa 1000, Ethiopia * Correspondence: [email protected]; Tel.: +86-10-6283-463 Received: 12 October 2019; Accepted: 20 December 2019; Published: 23 December 2019 Simple Summary: Sheep is one of the most economically important animals used as a source of meat, milk, wool, and fur for human society. These commodities are essential for human being. Body growth, body weight, carcass quality, fat percent, fertility, milk yield, wool, horn type and coat color are essential and useful sheep traits. Understanding the genetic background of these traits is paramount to increase the production and productivity of domestic animals. The availability of genomic data, development of molecular breeding techniques, and genome technologies have come to play a vital role in understanding the genetic background of different animal traits. This is directly or indirectly helpful for the practice of genetic improvement of economically important traits in sheep.
    [Show full text]
  • UBR2 Mediates Transcriptional Silencing During Spermatogenesis Via Histone Ubiquitination
    UBR2 mediates transcriptional silencing during spermatogenesis via histone ubiquitination Jee Young Ana,1, Eun-A. Kima,1, Yonghua Jianga,1, Adriana Zakrzewskaa, Dong Eun Kima, Min Jae Leeb, Inhee Mook-Jungc, Yi Zhangd, and Yong Tae Kwona,2 aCenter for Pharmacogenetics and Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261; bDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115; cDepartment of Biochemistry and Biomedical Science, Seoul National University College of Medicine, Seoul 110-799, Korea; and dDepartment of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 Edited by Alexander Varshavsky, California Institute of Technology, Pasadena, CA, and approved November 6, 2009 (received for review September 9, 2009) Ubiquitination of histones provides an important mechanism regu- Spermatogenesis involves one of the most dramatic chromatin- lating chromatin remodeling and gene expression. Recent studies remodeling processes, including synapsis and transcriptional have revealed ubiquitin ligases involved in histone ubiquitination, silencing. During the pachytene stage of meiosis, the X and Y yet the responsible enzymes and the function of histone ubiquitina- chromosomes are located into the nuclear periphery and form tion in spermatogenesis remain unclear. We have previously shown the XY body, where they achieve partial synapsis in the pseu- that mice lacking the ubiquitin ligase UBR2, one of the recognition E3 doautosomal region (PAR). In the XY body, the transcription components of the N-end rule proteolytic pathway, are infertile of genes linked to unsynapsed XY axes are silenced through a associated with meiotic arrest at prophase I. We here show that process called meiotic sex chromosome inactivation (MSCI) (9).
    [Show full text]
  • Epigenome Alterations in Aortic Valve Stenosis and Its Related Left
    Gošev et al. Clinical Epigenetics (2017) 9:106 DOI 10.1186/s13148-017-0406-7 REVIEW Open Access Epigenome alterations in aortic valve stenosis and its related left ventricular hypertrophy Igor Gošev1, Martina Zeljko2, Željko Đurić3, Ivana Nikolić4, Milorad Gošev5, Sanja Ivčević6, Dino Bešić7, Zoran Legčević7 and Frane Paić7* Abstract Aortic valve stenosis is the most common cardiac valve disease, and with current trends in the population demographics, its prevalence is likely to rise, thus posing a major health and economic burden facing the worldwide societies. Over the past decade, it has become more than clear that our traditional genetic views do not sufficiently explain the well-known link between AS, proatherogenic risk factors, flow-induced mechanical forces, and disease-prone environmental influences. Recent breakthroughs in the field of epigenetics offer us a new perspective on gene regulation, which has broadened our perspective on etiology of aortic stenosis and other aortic valve diseases. Since all known epigenetic marks are potentially reversible this perspective is especially exciting given the potential for development of successful and non-invasive therapeutic intervention and reprogramming of cells at the epigenetic level even in the early stages of disease progression. This review will examine the known relationships between four major epigenetic mechanisms: DNA methylation, posttranslational histone modification, ATP-dependent chromatin remodeling, and non-coding regulatory RNAs, and initiation and progression of AS. Numerous profiling and functional studies indicate that they could contribute to endothelial dysfunctions, disease-prone activation of monocyte-macrophage and circulatory osteoprogenitor cells and activation and osteogenic transdifferentiation of aortic valve interstitial cells, thus leading to valvular inflammation, fibrosis, and calcification, and to pressure overload-induced maladaptive myocardial remodeling and left ventricular hypertrophy.
    [Show full text]